Dr. Reddy’s Q3 Results: Surprise Loss On Impairment Costs
White capsules are displayed for a photograph at a manufactuting plant in South Carolina, U.S. (Photographer: Ariana Lindquist/Bloomberg)  

Dr. Reddy’s Q3 Results: Surprise Loss On Impairment Costs

Dr. Reddy’s Laboratories Ltd. posted a surprise loss in the quarter ended December on account of impairment costs.The drugmaker’s loss stood at Rs 570 crore in the October-December period against a...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.